CN Patent

CN108516966A — 达格列净的晶型及其制备方法和用途

Assigned to Zhejiang Hisun Pharmaceutical Co Ltd · Expires 2018-09-11 · 8y expired

What this patent protects

本发明涉及达格列净·(S)‑丙二醇·水合物晶型D的制备方法和用途。所述晶型在溶出时间、生物学释放、化学稳定性和加工适应性方面具有优异的性质。

USPTO Abstract

本发明涉及达格列净·(S)‑丙二醇·水合物晶型D的制备方法和用途。所述晶型在溶出时间、生物学释放、化学稳定性和加工适应性方面具有优异的性质。

Drugs covered by this patent

Patent Metadata

Patent number
CN108516966A
Jurisdiction
CN
Classification
—
Expires
2018-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Hisun Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.